Showing results (11-20 of 163) with videos related to
Sort By:
Pageof 17
Tissue Antigens|March 16, 2013
Lack of recognition of HLA class I mismatches outside α1/α2 domains by CD8+ alloreactive T lymphocytes: the HLA-B44 paradigmF Bettens, U Schanz, J-M TiercyBone Marrow Transplantation|August 24, 1999
Delaying treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for hematological malignancies: a prospective randomized trialI F Ciernik, U Schanz, J GmürHamostaseologie|May 30, 2013
Heparin-induced thrombocytopenia associated with thrombotic microangiopathyJ-D Studt, I Binet, G Nair, et al.Bone Marrow Transplantation|October 16, 2002
Late G-CSF after allogeneic bone marrow or peripheral blood stem cell transplantation: a prospective controlled trialB Himmelmann, A Himmelmann, K Furrer, et al.Transfusion|December 2, 2000
Transfusion of washed and centrifuged shed RBCs during maxillofacial surgery affects cytokine concentrationsR G Rohling, A P Zimmermann, R Zellweger, et al.Lancet (London, England)|November 16, 1991
Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemiaJ Gmür, J Burger, U Schanz, et al.Bone Marrow Transplantation|May 1, 1996
Feasibility and toxicity of interferon maintenance therapy after allogeneic BMT for multiple myeloma: a pilot study of the EBMTD Samson, L Volin, U Schanz, et al.Bone Marrow Transplantation|June 25, 2002
Contrast media triggering cutaneous graft-versus-host diseaseS R Vavricka, J Halter, K Furrer, et al.Schweizerische Medizinische Wochenschrift|December 8, 2000
[Neonatal alloimmune thrombocytopenia due to a rare anti-HPA-1b antibody]P Moosmann, J C Fauchère, J Halter, et al.Bone Marrow Transplantation|September 24, 2013
Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCTR Benz, U Schanz, M Maggiorini, et al.Pageof 17